Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165,157 | 208,393 | 167,495 | 279,834 | 104,424 |
| Marketable Securities | 129,653 | 129,550 | 118,808 | 130,871 | 184,008 |
| Receivables | 165,718 | 177,503 | 201,867 | 155,614 | 124,456 |
| Inventories | 35,752 | 32,018 | 26,649 | 21,808 | 14,812 |
| TOTAL | $540,362 | $589,691 | $613,392 | $693,785 | $517,262 |
| Non-Current Assets | |||||
| PPE Net | 85,031 | 82,129 | 79,492 | 72,590 | 66,889 |
| Intangibles | 505,683 | 533,970 | 768,546 | 788,232 | 832,231 |
| Other Non-Current Assets | 128,809 | 132,334 | 147,409 | 151,012 | 160,016 |
| TOTAL | $719,523 | $748,433 | $995,447 | $1,011,834 | $1,059,136 |
| Total Assets | $1,259,885 | $1,338,124 | $1,608,839 | $1,705,619 | $1,576,398 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 105,849 | 105,351 | 97,874 | 72,149 | 77,964 |
| Accounts payable and accrued liabilities | 370,731 | 358,562 | 332,091 | 320,366 | 329,322 |
| Other current liabilities | N/A | N/A | N/A | N/A | 1,312 |
| TOTAL | $492,118 | $476,342 | $441,634 | $406,236 | $420,076 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,230,643 | 1,233,872 | 1,237,768 | 1,257,459 | 962,931 |
| Deferred Revenues | 1,224 | 0 | 214 | 1,351 | N/A |
| Other Non-Current Liabilities | 138,823 | 138,066 | 266,983 | 267,501 | 264,510 |
| TOTAL | $1,438,577 | $1,441,050 | $1,624,766 | $1,646,469 | $1,383,226 |
| Total Liabilities | $1,930,695 | $1,917,392 | $2,066,400 | $2,052,705 | $1,803,302 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,463 | 75,345 | 74,191 | 73,815 | 71,882 |
| Common Shares | 75 | 75 | 73 | 72 | 71 |
| Retained earnings | -3,127,786 | -2,994,816 | -2,795,933 | -2,656,974 | -2,486,085 |
| Other shareholders' equity | 9,609 | -1,431 | -1,587 | 4,796 | 36,205 |
| TOTAL | $-670,810 | $-579,268 | $-457,561 | $-347,086 | $-226,904 |
| Total Liabilities And Equity | $1,259,885 | $1,338,124 | $1,608,839 | $1,705,619 | $1,576,398 |